Press release
 Canagliflozin Drug Market 2022 Size, Growth Analysis Report, Forecast to 2028
The canagliflozin drug market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Canagliflozin drug is prescribed in the treatment of type 2 diabetes. It lowers the blood sugar level in the body. A high concentration of blood sugar in the body is seen in type 2 diabetes. In this condition, the body lacks the production of insulin or functions it smoothly. Canagliflozin drug comes under a class of medication known as sodium-glucose cotransporter 2. This drug works on the kidneys to lower the sugar content which passes through urine. Type 2 diabetes is a chronic condition in which sugar circulation is increased in the bloodstream. High sugar content in the body leads to further ailments such as nervous and immune system disorders. Around 537 million adults were suffering from any type of diabetes globally in the year 2021.(Get 15% Discount on Buying this Report)
Click Here to Get a Free Sample Report of the Canagliflozin Drug Market @ https://orionmarketreports.com/request-sample/?id=109620&submit=Request+Sample%0D%0AÂ
Canagliflozin drug is also prescribed for cardiovascular disease. These are disorders of the heart and bloodstream. Various conditions under cardiovascular disease are - coronary artery disease, cerebrovascular disease, peripheral arterial disease, and rheumatic heart disease. Coronary artery disease is a condition in which cholesterol deposits in the walls of the artery. These arteries supply blood to the heart from the body. Blocking of this artery causes the heart to pump more to pass the blood which puts a strain on the heart. Cerebrovascular disease is a condition in which smooth blood to the brain is hampered.Â
Scope of the Canagliflozin Drug Report
The research study analyzes the Canagliflozin Drug industry from a 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:
Recent Developments
Market Overview and growth analysis
Import and Export Overview
Volume Analysis
Current Market Trends and Future Outlook
Market Opportunistic and Attractive Investment Segment
A full report of Canagliflozin Drug Market is available at: https://orionmarketreports.com/canagliflozin-drug-market/109620/Â
Canagliflozin Drug Market Segmentation:
By Disease
Type 2 Diabetes
Cardiovascular Disease
End-Stage Renal Disease
By End-User
Hospital
Clinic
Others
Competitive Landscape- Janssen Global Services, LLC, Dr. Reddy's Laboratories Ltd., Mitsubishi Tanabe Pharma Corp.
Geographic Coverage
North America Market Size and/or Volume
Latin America Market Size and/or Volume
Europe Market Size and/or Volume
Asia-Pacific Market Size and/or Volume
Rest of the world Market Size and/or Volume
Key questions answered in this report:
What is the size of the Canagliflozin Drug market and what is its expected growth rate?
What are the primary driving factors that push the Canagliflozin Drug Market forward?
What are the Canagliflozin Drug Industry's top companies?
What are the different categories that the Canagliflozin Drug Market caters to?
What will be the fastest-growing segment or region?
In the value chain, what role do essential players play?
What is the procedure for getting a free copy of the Canagliflozin Drug Market sample report and company profiles?
The report covers the following objectives:
Proliferation and maturation of trade in the Canagliflozin Drug market.
The market share of the Canagliflozin Drug market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
Current and future market trends that are influencing the growth opportunities and growth rate of the Canagliflozin Drug market.
Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the Canagliflozin Drug market.
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
About Us:
Orion Market Reports (OMR) endeavor to provide an exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release  Canagliflozin Drug Market 2022 Size, Growth Analysis Report, Forecast to 2028 here
News-ID: 2636594 • Views: …
More Releases from orionmarketreports

Electric Scooters Market Update Report 2024 | Industry Trends, Demand, Leading C …
Electric Scooters market is anticipated to grow at a CAGR of 12.4% during the forecast period (2024-2031). The electric scooters market comprises the production and distribution of electrically powered scooters for personal transportation. These scooters, equipped with electric motors and batteries, offer a sustainable alternative to traditional gasoline-powered models. Rising environmental awareness, government incentives, and battery technology advancements drive market growth, catering to diverse commuting and urban mobility needs.
Get Free…

Healthcare Digital Signage Market Size, Trends, Latest Insights, Analysis and Fo …
Global Healthcare Digital Signage market is anticipated to grow at a CAGR of 8.9% during the forecast period (2024-2031). A major factor supporting the growth of the market is advancements in technologies such as high-resolution displays, touch screens, and other features that have enhanced communication and patient engagement in hospitals, clinics, and pharmacies that efficiently communicate crucial information to patients, visitors, and staff, displaying real-time updates, appointment reminders, health education, and wayfinding…

Biopreservation Market Increasing Demand, Growth Analysis and Future Outlook by …
Biopreservation market is growing significantly in the near future. Biopreservation is a technique primarily used for the preservation of a wide range of products including organs, tissues, and cells outside their native environment. The method of biopreservation extends the shelf life of various products also ensures the purity and stability of organs, tissues, and cells that are preserved. This Biopreservation Market research report focuses more on a number of distinctive as…

Lithium-ion Battery Separator Market Update Report 2024 | Industry Trends, Deman …
Lithium-ion Battery Separator market is anticipated to grow at a CAGR of 8.4% during the forecast period (2024-2031). Lithium-ion Battery Separator is a thin, porous membrane placed between the positive and negative electrodes of a lithium-ion battery. It serves to physically separate the electrodes while allowing the flow of lithium ions between them during charging and discharging cycles. The separator is typically made of polymeric materials such as polyethylene (PE)…
More Releases for Canagliflozin
Top Market Shifts Transforming the Empagliflozin, Dapagliflozin And Canagliflozi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Empagliflozin, Dapagliflozin And Canagliflozin Market Through 2025?
In recent times, the market size for empagliflozin, dapagliflozin, and canagliflozin has consistently expanded. Projected growth suggests an increase from $9.64 billion in 2024 to $9.94 billion in 2025, marking a compound annual growth rate…
Global Empagliflozin, Dapagliflozin And Canagliflozin Market Outlook 2025-2034: …
The Empagliflozin, Dapagliflozin And Canagliflozin Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Empagliflozin, Dapagliflozin And Canagliflozin Market Size and Projected Growth Rate?
The empagliflozin, dapagliflozin and canagliflozin market size has grown steadily in recent years. It will grow from $9.64 billion in…
Empagliflozin, Dapagliflozin And Canagliflozin Market Report By Size, Share And …
The Business Research Company recently released a comprehensive report on the Global Empagliflozin, Dapagliflozin And Canagliflozin Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free…
Empagliflozin, Dapagliflozin And Canagliflozin Market Size, Share Analysis And T …
The new report published by The Business Research Company, titled Empagliflozin, Dapagliflozin And Canagliflozin Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the empagliflozin, dapagliflozin and canagliflozin market size has grown steadily in recent years. It will grow from…
Empagliflozin, Dapagliflozin and Canagliflozin Market Research Report 2023: …
Empagliflozin, Dapagliflozin and Canagliflozin are three main types of SGLT-2 inhibitors.
Global Empagliflozin, Dapagliflozin and Canagliflozin Market: Driven factors and Restrictions factors
The research report encompasses a comprehensive analysis of the factors that affect the growth of the market. It includes an evaluation of trends, restraints, and drivers that influence the market positively or negatively. The report also outlines the potential impact of different segments and applications on the market in the…
Huateng Pharma Supplies Canagliflozin Intermediates With Commercial Scale Produc …
Canagliflozin is a medication used to treat type 2 diabetes. It is a third-line medication to be tried after metformin, a first-line medication for type 2 diabetes. It is used together with exercise and diet. It is not recommended in type 1 diabetes.
Mechanism action of Canagliflozin
Canagliflozin is a sodium-glucose cotransporter (SGLT2) inhibitor. Glucose filtered in the renal tubular lumen is mainly reabsorbed by SGLT2 expressed in the proximal renal…